Outpace Bio
Chad Green is an accomplished professional in the biotechnology field with extensive experience in technical operations and quality management. Currently serving as Head of Technical Operations and Quality at Outpace Bio since February 2025, Chad previously held the role of Senior Vice President of Technical Operations at Innervace, specializing in regenerative therapies for conditions such as Parkinson's disease. Chad also contributed as Senior Vice President of Technical Operations at Turnstone Biologics, overseeing process development and regulatory responsibilities. Prior positions include Senior Principal at Dark Horse Consulting Group, Senior Director of Technical Operations at Fate Therapeutics, and various roles at ViaCyte focused on device engineering and manufacturing. Chad's early career involved postdoctoral research at both the University of California at San Diego and the University of California at Davis, alongside foundational education culminating in a Ph.D. in Biomedical Engineering from the University of California, Davis.
This person is not in any teams
This person is not in any offices
Outpace Bio
Outpace Bio is a biotechnology company that creates smart cell therapies aimed at improving efficacy and safety.It offers a platform that combines custom-designed biological functions with cellular control modalities that program the right response at the right time and place. It creates a mechanism-driven solution tailor-made to improve efficacyand safety. The company collaborates with Lyell Immunopharma to develop and commercialize a potential immune cell therapy for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders, enabling healthcare providers to cure a wide range of diseases as per patient's need.